Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of ONO-7056 (salirasib) in patients with solid tumors
jRCT2080221709Phase 1
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of salirasib in Nonhematologic neoplasms, sponsored by Ono Pharmaceutical.
02
Drugs
salirasib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080221709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221709.